FGEN (FibroGen, Inc.) Earnings per share growth rate in current year
A critical capital reduction and the threat of delisting following failures with pamrevlumab have placed serious pressure on FibroGen, Inc. (FGEN). FibroGen, Inc. (FGEN) generates revenue from the commercialization of fibrosis and anemia treatments, including partner payments. The brand's scientific authority is confirmed by the success of roxadustat. Looking at the annual earnings per share change on GURU.Markets, we see that the value of this metric is 61.80.
Financial and market metric breakdowns for FibroGen, Inc. (FGEN)
- stock price and consensus target price:
- business market valuation indicators:
- balance sheet equity data:
- debt and liquidity details:
- net income and valuation multiples indicators:
FGEN - Net Profit|Expected Net Profit FibroGen, Inc.|FGEN - Price to Earnings Ratio|Price to Future Earnings Ratio FibroGen Corporation|FGEN - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation FibroGen Corporation|FGEN - Operating profit EBITDA|Net earnings per share for the last four quarters FibroGen|FGEN - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last 12 months fibrogen.com|FGEN - Earnings growth in current year|Expected earnings per share growth for next year FibroGen, Inc.
Basic company analysis:FibroGen Inc (FGEN)
This metric measures the year-over-year dynamics of net earnings per share, determining the growth or decline rates of the business's actual earnings over a twelve-month period. By analyzing the annual EPS growth indicator, an investor filters out market noise. For FibroGen, Inc. (FGEN), this reflects the commercialization efficiency of the drug Evaren within the nephrology segment. A positive trend confirms the successful substitution of injections with the oral form.
Main competitors
Haleon PLC - Earnings per share increase in current year|KVUE (Kenvue Corp) - Earnings growth in current year|Earnings per share growth rate in current year Verona Pharma Inc. VRNA|Earnings per share growth in current year Jyong Biotech Ltd (MENS)|LGND (ligand.com) - Earnings per share increase in current year|Earnings growth in current year AMRX (Amneal)|PRGO (Perrigo Company PLC) - Earnings per share trend in current year|Alvotech Corp - Earnings growth in current year|Expected net earnings per share growth this year Liquidia Inc. LQDA|GLPG: Earnings growth in current year|ANIP (anipharmaceuticals.com) - Earnings per share growth in current year|Earnings per share growth in current year MannKind|AMPH: Earnings per share increase in current year|Earnings per share growth in current year Pacira (PCRX)|SPRY - Earnings per share growth rate in current year|Earnings growth in current year TBPH (Theravance Biopharma)|Net earnings per share change in current year aquestive.com|scPharma - Earnings growth in current year|Earnings per share growth rate in current year Tectonic Therapeutic, Inc.|Tonix Pharmaceuticals Inc. (TNXP) - Earnings per share growth in current year|Earnings per share growth this year SXTC|Net earnings per share growth this year EPRX|BHST: Earnings per share increase in current year|Earnings growth in current year EXOZ|Expected net earnings per share growth this year oramed.com|Earnings per share growth in current year Entera Bio ENTX|HYFT: Earnings per share growth this year|ABVC BioPharma - Earnings growth in current year|cumberlandpharma.com (CPIX) - Net earnings per share growth this year|QNTM (Quantum BioPharma) - Net earnings per share growth this year|TELO - Expected net earnings per share growth this year|RANI (Rani Therapeutics Holdings) - Earnings growth in current year|Synergy CHC Corporation - Earnings per share trend in current year|Earnings growth in current year RLYB|lexariabioscience.com (LEXX) - Net earnings per share change in current year|Earnings growth in current year PULM (Pulmatrix)|Pheton Holdings Limited (PTHL) - Earnings per share growth rate in current year|APM - Earnings per share growth in current year|LYRA (Lyra Therapeutics Inc) - Earnings per share growth this year|Impact BioMedical (IBO) - Earnings per share growth in current year|Earnings per share trend in current year TNFA (TNF Pharmaceuticals, Inc.)|YCBD (cbdMD Inc.) - Earnings growth in current year|PRFX: Earnings per share increase in current year|Earnings growth in current year CYTO|Earnings growth in current year Lipella Pharma (LIPO)|Earnings per share growth in current year OptiNose, Inc. OPTN|Earnings per share increase in current year PIRS|PROC - Earnings per share growth in current year|Petros Pharmaceuticals Inc (PTPI) - Net earnings per share growth this year|QLI: Earnings growth in current year|ACELYRIN Inc. (SLRN) - Earnings growth in current year|Net earnings per share growth this year TFFP
